BioVaxys Technology Corp. (BVAXF)
OTCMKTS
· Delayed Price · Currency is USD
0.0234
+0.0005 (2.18%)
May 6, 2025, 3:54 PM EDT
BioVaxys Technology Market Cap
BioVaxys Technology has a market cap or net worth of $6.37 million as of May 6, 2025. Its market cap has decreased by -53.77% in one year.
Market Cap
6.37M
Enterprise Value
6.31M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since October 6, 2020, BioVaxys Technology's market cap has decreased from 20.38M to 6.37M, a decrease of -68.73%. That is a compound annual growth rate of -22.42%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 5, 2025 | 6.37M | -44.36% |
Dec 31, 2024 | 11.45M | 108.44% |
Dec 29, 2023 | 5.49M | -46.60% |
Dec 30, 2022 | 10.29M | -31.16% |
Dec 31, 2021 | 14.94M | 33.01% |
Dec 31, 2020 | 11.23M | -44.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo Inc. | 1.62B |
Nika Pharmaceuticals | 1.02B |
Veradigm | 746.57M |
Tian'an Technology Group | 546.22M |
Glass House Brands | 529.49M |
Elite Pharmaceuticals | 452.95M |
Northwest Biotherapeutics | 429.16M |
CytoDyn | 401.57M |